Published in Heart on April 01, 2004
Pharmacogenomics and end-organ susceptibility to injury in the perioperative period. Best Pract Res Clin Anaesthesiol (2008) 0.75
Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med (1997) 18.85
The pathogenesis of coronary artery disease and the acute coronary syndromes (1). N Engl J Med (1992) 6.41
Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group. N Engl J Med (1995) 5.24
Platelet aggregation in partially obstructed vessels and its elimination with aspirin. Circulation (1976) 2.87
Myocardial ischaemia during daily life in patients with stable angina: its relation to symptoms and heart rate changes. Lancet (1983) 2.70
Coronary arterial smooth muscle contraction by a substance released from platelets: evidence that it is thromboxane A2. Science (1976) 2.39
Silent ischemia during daily life is an independent predictor of mortality in stable angina. Circulation (1990) 2.02
Increased proinflammatory cytokines in patients with chronic stable angina and their reduction by aspirin. Circulation (1999) 1.99
The biology of CSF-1 and its receptor. Curr Top Microbiol Immunol (1992) 1.55
Thrombospondin binds to monocytes-macrophages and mediates platelet-monocyte adhesion. J Clin Invest (1987) 1.53
Regulation of monocyte CD36 and thrombospondin-1 expression by soluble mediators. Arterioscler Thromb Vasc Biol (1996) 1.45
Clinical significance of increased plasma concentration of macrophage colony-stimulating factor in patients with angina pectoris. J Am Coll Cardiol (2000) 1.18
Morphology of the endothelium over atherosclerotic plaques in human coronary arteries. Br Heart J (1988) 1.14
Morphological characteristics of clinically significant coronary artery stenosis in stable angina. Br Heart J (1986) 1.07
Reactivity of eccentric and concentric coronary stenoses in patients with chronic stable angina. J Am Coll Cardiol (1991) 0.99
Generation of the combined prothrombin activation peptide (F1-2) during the clotting of blood and plasma. J Clin Invest (1977) 0.99
Effects of platelet inhibition on myocardial ischaemia. Lancet (1982) 0.97
Inflammatory and procoagulant mediator interactions in an experimental baboon model of venous thrombosis. Thromb Haemost (1993) 0.93
Low-grade exercise enhances platelet aggregability in patients with obstructive coronary disease independently of myocardial ischemia. Am J Cardiol (2001) 0.87
Pharmacology of platelet inhibition in humans: implications of the salicylate-aspirin interaction. Circulation (1985) 0.86
Common variations in platelet glycoproteins: pharmacogenomic implications. Pharmacogenomics (2001) 0.85
High-dose aspirin inhibits shear-induced platelet reaction involving thrombin generation. Circulation (1992) 0.84
Prostaglandin and thromboxane biosynthesis in isolated platelet-free human monocytes. III. The induction of cycloxygenase by colony stimulating factor-1. Prostaglandins Leukot Essent Fatty Acids (1989) 0.81
Dose-dependent influence of acetylsalicyclic acid on platelet functions and plasmatic coagulation factors. Haemostasis (1976) 0.81
Polar expression of tissue factor in human umbilical vein endothelial cells. Arterioscler Thromb (1994) 0.81
Thromboxane biosynthesis and metabolism in relation to cardiovascular risk factors. Trends Cardiovasc Med (2011) 0.77
Colony-stimulating factor-1 induces thromboplastin activity in murine macrophages and human monocytes. J Cell Physiol (1987) 0.77
The role of extraplatelet thromboxane A2 in unstable angina investigated with a dual thromboxane A2 inhibitor: importance of activated monocytes. Coron Artery Dis (1994) 0.77
Silent ischemia as a central problem: regional brain activation compared in silent and painful myocardial ischemia. Ann Intern Med (1996) 6.11
Cardiac syndrome X: clinical characteristics and left ventricular function. Long-term follow-up study. J Am Coll Cardiol (1995) 2.89
Accreditation in transoesophageal echocardiography: statement from the Association of Cardiothoracic Anaesthetists and the British Society of Echocardiography Joint TOE Accreditation Committee. Br J Anaesth (2003) 2.64
Echocardiographic measurement of the normal adult right ventricle. Br Heart J (1986) 2.16
Anatomy, echocardiography, and normal right ventricular dimensions. Heart (2006) 2.03
Increased proinflammatory cytokines in patients with chronic stable angina and their reduction by aspirin. Circulation (1999) 1.99
Ebstein's anomaly: presentation and outcome from fetus to adult. J Am Coll Cardiol (1994) 1.95
Arrhythmia and prognosis in infants, children and adolescents with hypertrophic cardiomyopathy. J Am Coll Cardiol (1988) 1.77
Accuracy and feasibility of contrast echocardiography for detection of perfusion defects in routine practice: comparison with wall motion and technetium-99m sestamibi single-photon emission computed tomography. The Nycomed NC100100 Investigators. J Am Coll Cardiol (1998) 1.64
Congenital fistula between the aorta and left atrium. Br Heart J (1987) 1.61
Clinical significance of giant negative T waves in hypertrophic cardiomyopathy. J Am Coll Cardiol (1990) 1.60
Natural history of secundum atrial septal defect in adults after medical or surgical treatment: a historical prospective study. Br Heart J (1994) 1.59
The C807T/G873A polymorphism in the platelet glycoprotein Ia gene and the risk of acute coronary syndrome in the Italian population. Br J Haematol (2001) 1.57
Platelet aggregability in cardiac syndrome X. Eur Heart J (2001) 1.52
Assessing right ventricular function: the role of echocardiography and complementary technologies. Heart (2006) 1.50
Allelic polymorphism of the interleukin-1 receptor antagonist gene in patients with acute or stable presentation of ischemic heart disease. Cardiologia (1999) 1.50
Hypertrophic cardiomyopathy without hypertrophy: two families with myocardial disarray in the absence of increased myocardial mass. Br Heart J (1990) 1.49
Q waves in hypertrophic cardiomyopathy in relation to the distribution and severity of right and left ventricular hypertrophy. J Am Coll Cardiol (1990) 1.45
Echocardiographic pitfalls in the diagnosis of hypertrophic cardiomyopathy. Heart (1999) 1.45
Genetic testing for familial hypertrophic cardiomyopathy in newborn infants. BMJ (1995) 1.44
Usefulness of echocardiography to differentiate dilated cardiomyopathy from coronary-induced congestive heart failure. Am J Cardiol (1991) 1.43
Angiosarcoma of the heart causing cardiac rupture: a rare cause of hemopericardium. Ann Thorac Surg (1993) 1.42
QT interval in cardiac amyloidosis. Clin Cardiol (1996) 1.41
Central role of echocardiography in the diagnosis and assessment of heart failure. British Society of Echocardiography. Heart (1998) 1.38
Natural history of early aortic paraprosthetic regurgitation: a five-year follow-up. Am Heart J (1999) 1.35
Progressive cardiac amyloidosis following liver transplantation for familial amyloid polyneuropathy: implications for amyloid fibrillogenesis. Transplantation (1998) 1.35
Relation of the -174 G/C polymorphism of interleukin-6 to interleukin-6 plasma levels and to length of hospitalization after surgical coronary revascularization. Am J Cardiol (2001) 1.21
Identification of a mutation in the beta cardiac myosin heavy chain gene in a family with hypertrophic cardiomyopathy. Br Heart J (1993) 1.15
Pexelizumab in ischemic heart disease: a systematic review and meta-analysis on 15,196 patients. J Thorac Cardiovasc Surg (2008) 1.14
Echocardiographic measurement of right ventricular wall thickness in hypertrophic cardiomyopathy: relation to clinical and prognostic features. J Am Coll Cardiol (1988) 1.13
QT-interval abnormalities in hypertrophic cardiomyopathy. Clin Cardiol (1992) 1.11
A new strategy for the assessment of viable myocardium and regional myocardial blood flow using 15O-water and dynamic positron emission tomography. Circulation (1992) 1.07
Setting up a transoesophageal echocardiography service. Br Heart J (1994) 1.07
Extent and severity of atherosclerotic involvement of the aortic valve and root in familial hypercholesterolaemia. Heart (1998) 1.07
Echocardiographic measures of left ventricular structure and their relation with rest and ambulatory blood pressure in blacks and whites in the United Kingdom. J Am Coll Cardiol (1994) 1.07
Angiotensin II increases plasminogen activator inhibitor type 1 and tissue-type plasminogen activator messenger RNA in cultured rat aortic smooth muscle cells. Circulation (1994) 1.02
Lipomatous hypertrophy of the interatrial septum: a commonly misdiagnosed mass often leading to unnecessary cardiac surgery. Heart (2004) 1.02
Aortic stenosis in homozygous familial hypercholesterolaemia. Heart (1996) 1.01
Relationship between hemostatic abnormalities and neuroendocrine activity in heart failure. Am Heart J (1994) 1.01
Aspirin to prevent growth of vegetations and cerebral emboli in infective endocarditis. J Intern Med (1992) 1.01
Marked variation in the cardiomyopathy associated with Friedreich's ataxia. Heart (1999) 1.00
Diffuse reduction of myocardial beta-adrenoceptors in hypertrophic cardiomyopathy: a study with positron emission tomography. J Am Coll Cardiol (1993) 0.99
Utility of echocardiography in assessment of pulmonary hypertension secondary to COPD. Eur Respir J (2001) 0.98
Echocardiographic evaluation of cardiac dyssynchrony for predicting a favourable response to cardiac resynchronisation therapy. Heart (2004) 0.98
Preoperative prediction of the outcome of coronary revascularization using positron emission tomography. Circulation (1992) 0.97
Increased prevalence of the G20210A prothrombin gene variant in acute coronary syndromes without metabolic or acquired risk factors or with limited extent of disease. Eur Heart J (2002) 0.96
Sarcoidosis: a pattern of clinical and morphological presentation. Br Heart J (1987) 0.96
Absence of atherosclerotic lesions in the thoracic aorta indicates absence of significant coronary artery disease. Am J Cardiol (1996) 0.94
The electrocardiogram is a more sensitive indicator than echocardiography of hypertrophic cardiomyopathy in families with a mutation in the MYH7 gene. Br Heart J (1994) 0.93
Echocardiographic characterization of cardiomyopathy in Friedreich's ataxia with tissue Doppler echocardiographically derived myocardial velocity gradients. Circulation (2000) 0.92
Coronary vasodilator reserve in primary and secondary left ventricular hypertrophy. A study with positron emission tomography. Eur Heart J (1997) 0.92
Myocardial beta adrenoceptors and left ventricular function in hypertrophic cardiomyopathy. Heart (1996) 0.91
Adjustment for the influence of age and heart rate on Doppler measurements of left ventricular filling. Br Heart J (1992) 0.91
Expert position paper on the use of proton pump inhibitors in patients with cardiovascular disease and antithrombotic therapy. Eur Heart J (2013) 0.91
Right ventricular abnormalities in ventricular tachycardia of right ventricular origin: relation to electrophysiological abnormalities. Br Heart J (1986) 0.91
Effects of cardiac resynchronisation therapy in patients with heart failure having a narrow QRS Complex enrolled in PROSPECT. Heart (2010) 0.90
Investigation of a hemodynamic basis for syncope in hypertrophic cardiomyopathy. Use of a head-up tilt test. Circulation (1992) 0.90
Clinical evaluation of left heart Doppler contrast enhancement by a saccharide-based transpulmonary contrast agent. The Levovist Cardiac Working Group. J Am Coll Cardiol (1995) 0.90
Markedly reduced insulin-like growth factor-1 in the acute phase of myocardial infarction. J Am Coll Cardiol (2001) 0.89
Duration of symptoms and the effects of a more aggressive surgical policy: two factors affecting prognosis of infective endocarditis. Eur Heart J (1985) 0.89
Comparison of dobutamine and treadmill exercise echocardiography in inducing ischemia in patients with coronary artery disease. J Am Coll Cardiol (1997) 0.89
Transient myocardial ischemia during daily life in patients with syndrome X. Am J Cardiol (1986) 0.88
Extreme variability of skeletal and cardiac muscle involvement in patients with mutations in exon 11 of the lamin A/C gene. Muscle Nerve (2005) 0.87
Stress echocardiography for assessing myocardial ischaemia and viable myocardium. Heart (1997) 0.87
How to quantitate valve regurgitation by echo Doppler techniques. British Society of Echocardiography. Br Heart J (1995) 0.85
Uses and limitations of high dose dipyridamole stress echocardiography for evaluation of coronary artery disease. Br Heart J (1992) 0.85
The standard electrocardiogram as a screening test for hypertrophic cardiomyopathy. Am J Cardiol (1995) 0.85
Non-bacterial thrombotic endocarditis. Eur J Echocardiogr (2000) 0.85
Comparison of usefulness between exercise capacity and echocardiographic indexes of left ventricular function in cardiac amyloidosis. Am J Cardiol (1999) 0.84
Report on the European Association of Echocardiography accreditations in echocardiography: December 2003-September 2006. Eur J Echocardiogr (2006) 0.84
Echocardiographic features of primary, secondary and familial amyloidosis. Eur J Clin Invest (1999) 0.84
The effect of age on vascular compliance in man: which are the appropriate measures? J Hum Hypertens (1999) 0.84
Hyperdynamic performance of remote myocardium in acute infarction. Correlation between regional contractile function and myocardial perfusion. Eur Heart J (1995) 0.84
Women in cardiology: a European perspective. Heart (2005) 0.84
The effect of long-term training on age-related left ventricular changes by Doppler myocardial velocity gradient. Am J Cardiol (1999) 0.84
Echocardiographic assessment of artificial heart valves: British Society of Echocardiography position paper. Br Heart J (1994) 0.84
Parenteral anticoagulants in heart disease: current status and perspectives (Section II). Position paper of the ESC Working Group on Thrombosis-Task Force on Anticoagulants in Heart Disease. Thromb Haemost (2013) 0.84
A simple assay for platelet-mediated hemostasis in flowing whole blood (PFA-100): reproducibility and effects of sex and age. Cardiologia (1999) 0.83
Elevated plasma endothelin concentrations in heart failure; an effect of angiotensin II? Eur Heart J (1994) 0.82
Intracardiac contrast echoes during transvenous His bundle ablation. Br Heart J (1985) 0.82
A comparison of left ventricular abnormalities associated with glucose intolerance in African Caribbeans and Europeans in the UK. Heart (2001) 0.82
Tricuspid valvectomy following tricuspid valve endocarditis on an intravenous drug addict. Heart (2001) 0.81
Differentiation between restrictive cardiomyopathy and constrictive pericarditis by early diastolic doppler myocardial velocity gradient at the posterior wall. Circulation (2000) 0.81
Significance of persistent left ventricular dysfunction during recovery after dobutamine stress echocardiography. J Am Coll Cardiol (1997) 0.81
Right ventricular pacing wire thrombus presenting as pyrexia of unknown origin. Clin Cardiol (1989) 0.81
G20210A prothrombin gene polymorphism and coronary ischaemic syndromes: a phenotype-specific meta-analysis of 12 034 subjects. Heart (2004) 0.81
Low-molecular-weight heparins vs. unfractionated heparin in the setting of percutaneous coronary intervention for ST-elevation myocardial infarction: a meta-analysis. J Thromb Haemost (2011) 0.81
Female sex as an independent risk factor for stroke in atrial fibrillation: possible mechanisms. Thromb Haemost (2013) 0.81
Autonomic function in hypertrophic cardiomyopathy. Br Heart J (1993) 0.80
Ximelagatran/melagatran against conventional anticoagulation: a meta-analysis based on 22,639 patients. Int J Cardiol (2007) 0.80
Differences in the association between type 2 diabetes and impaired microvascular function among Europeans and African Caribbeans. Diabetologia (2005) 0.80
Diagnostic value of two-dimensional echocardiography in cardiac hydatid disease. Eur Heart J (1991) 0.80